J. S. de Bono Et Al. , "Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial," LANCET , vol.376, no.9747, pp.1147-1154, 2010
de Bono, J. S. Et Al. 2010. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. LANCET , vol.376, no.9747 , 1147-1154.
de Bono, J. S., Oudard, S., Ozguroglu, M., Hansen, S., Machiels, J., Kocak, I., ... Gravis, G.(2010). Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. LANCET , vol.376, no.9747, 1147-1154.
de Bono, Johann Et Al. "Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial," LANCET , vol.376, no.9747, 1147-1154, 2010
de Bono, Johann S. Et Al. "Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial." LANCET , vol.376, no.9747, pp.1147-1154, 2010
de Bono, J. S. Et Al. (2010) . "Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial." LANCET , vol.376, no.9747, pp.1147-1154.
@article{article, author={Johann Sebastian de Bono Et Al. }, title={Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial}, journal={LANCET}, year=2010, pages={1147-1154} }